Friday, 27th March 2026 14:00-17:00 (CET)

 

We are pleased to announce the workshop “In silico and in vitro approaches to assess biodegradability and prioritize environmentally friendly chemotypes of synthetic and natural origin” organized in the context of the COST Action 21111 OneHealthdrugs – “One Health drugs against parasitic vector-borne diseases in Europe and beyond” (https://onehealthdrugs.com). The COST Action network aims to coordinate the discovery of drugs that stop vector-borne infections in both human and veterinary settings according to the principles of the optimal profile for these organisms, increasing quality and reducing environmental impact.

The workshop is jointly organized by WG1, WG2, WG3 and HG7 and will cover innovative models (in silico and experimental) at the interface of drug discovery for VBDs and (eco)toxicology including biodegradability. This collaborative event will provide a platform for scientists, academics, young researchers and industry professionals to share insights, methodologies, advancements, a pipeline and portfolio of approaches in the pursuit of environmentally conscious antiparasitic drug discovery.

------------

We invite contributions from researchers and experts within the OneHealthdrugs network. Abstracts will be

selected based on the coherence to the topic and time of application. Other criteria will be country of affiliation,

career stage, CA21111 participation and previous funding from the COST Action. Please submit your abstract to

Theodora Calogeropoulou (tcalog@eie.gr), Sandra Gemma (gemma@unisi.it), Guy Caljon

(Guy.Caljon@uantwerpen.be). The abstract template can be downloaded here

https://docs.google.com/document/d/1Q_j8BwtotTUHjzCo9K0CTjghyYG1sBD5/export?format=docx

The event registration requires two steps : 1) create an e-COST account in the www.cost.eu and 2) register here:

https://docs.google.com/forms/d/e/1FAIpQLScm_Wwf1iF4ZjCi_WkF_S9VZrRLUTFSJ7FVViFvoPNqxxk_Ug/viewfo

rm?usp=publish-editor

Program - In silico and in vitro approaches to assess biodegradability and prioritize environmentally friendly chemotypes of synthetic and natural origin -

 

Friday 27th March 2026

14:00-14:05 Opening remarks: Ulrike Wittig (WG1), Theodora Carogeropoulou

(WG2), Guy Caljon (WG3), Sandra Gemma (HG7) Maria Paola Costi

(Action Chair)

 

14:05-14:20 Green Drug Score for ranking compounds from virtual screening

approaches in the drug discovery process. - Daniele Aiello Department

of Life Science University of Modena and Reggio Emilia

 

14:20 - 15:00 In vivo evaluation of biodegradation of chemical susbstances – Gerald Thouand Nantes Université

 

15:00 – 15:40 Integrating Bioavailability into Persistence Testing to Improve

Prospective Environmental Risk Assessment of Organic Chemicals -

Jose-Julio Ortega-Calvo Instituto de Recursos Naturales y Agrobiología

de Sevilla, CSIC, Spain

 

15:40 – 16:00 Annotation of compounds using in-silico methods Reagon Karki

 

16:00 – 16:20 Innovations in bio-assays employed in drug discovery Sheraz Gul

Fraunhofer Institute for Translational Medicine & Pharmacology, Germany

 

16:20 – 16:40 Integration of Metabolite Prediction in the G.AI.A Platform for

Ecotoxicity Assessment Eleni Chontzopoulou Cloudpharm PC, Athens

15125, Greece

16.40 -16.50 Updates on OneHealthDrugs by the Action chair – Prof. Maria Paola

Costi Department of Life Science University of Modena and Reggio

Emilia

16:50 – 17:00 Discussion and concluding remarks

Summary of the workshop

Short updates about OneHealthdrugs March 2026

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Wioleta Walentowska
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi